Junya Ohmori

Title: Junya Ohmori: Innovator in Pharmaceutical Chemistry

Introduction

Junya Ohmori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, Ohmori's work focuses on innovative solutions for treating various mental health conditions.

Latest Patents

Ohmori's latest patents include an imidazo[1,2-a]pyridine derivative aimed at providing a compound useful as medicine with PDE4B inhibitory activity. This compound is particularly relevant for treating or preventing schizophrenia, Alzheimer's disease, dementia, and depression. The invention highlights the discovery of tricyclic or tetracyclic imidazo[1,2-a]pyridine derivatives that exhibit superior PDE4B inhibitory activity. Another notable patent involves a salt of a 1,3,5-triazine-2,4,6-triamine derivative, which offers uniform crystal forms of specific compounds that are useful as medicaments or starting materials for drug preparation.

Career Highlights

Junya Ohmori is currently associated with Astellas Pharma GmbH, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that address critical health issues.

Collaborations

Ohmori has collaborated with notable colleagues, including Noriyuki Kawano and Kiyohiro Samizu. Their combined expertise has contributed to the successful development of innovative pharmaceutical compounds.

Conclusion

Junya Ohmori's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. His patents reflect a commitment to addressing significant medical challenges through scientific discovery.